ArticleThe oncologist2021

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.

Clarisse Dromain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.